BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 24112176)

  • 1. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
    Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB
    Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis.
    Ruan XL; Li S; Meng XY; Geng P; Gao QP; Ao XB
    Medicine (Baltimore); 2015 Sep; 94(38):e1588. PubMed ID: 26402821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analyses of the effect of CYP1A1 and CYP2D6 polymorphisms on the risk of head and neck squamous cell carcinoma.
    Han J; Wang L; Yang Y; Zhang J
    Oncol Res Treat; 2014; 37(7-8):406-11. PubMed ID: 25138301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of CYP2D6 influences susceptibility to papillary thyroid cancer.
    Lemos MC; Carrilho F; Rodrigues F; Coutinho E; Gomes L; Carvalheiro M; Regateiro FJ
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):180-3. PubMed ID: 17547692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms.
    van der Padt A; van Schaik RH; Sonneveld P
    Neth J Med; 2006 May; 64(5):160-2. PubMed ID: 16702617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between cytochrome P450 2D6 gene polymorphism and risk of acute leukemia: evidence based on a meta-analysis.
    Ruan XL; Li S; Zeng XT; Xia LH; Hu Y
    Chin Med J (Engl); 2013; 126(19):3750-3. PubMed ID: 24112176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.
    Neafsey P; Ginsberg G; Hattis D; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
    Ur Rasheed MS; Mishra AK; Singh MP
    Neurochem Res; 2017 Dec; 42(12):3353-3361. PubMed ID: 28871472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between cytochrome P450 2D6 and lung cancer susceptibility caused by smoking].
    Yan Z; Wu Y; Wu Y
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):112-3, 116. PubMed ID: 17424863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits.
    Dorado P; Peñas-Lledó EM; Llerena A
    Pharmacogenomics; 2007 Nov; 8(11):1597-608. PubMed ID: 18034624
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.